Abstract
Growth factors involved in neurogenesis and neuroplasticity could play a role in biological processes that drive depression recovery. Combined total sleep deprivation and morning light therapy (TSD + LT) can acutely reverse depressive symptoms, thus allowing to investigate the neurobiological correlates of antidepressant response. We tested if changes on plasma levels of Brain Derived Neurotrophic Factor (BDNF), S100 calcium binding protein B (S100-B), Stem Cell Factor (SCF), Insulin-like Growth Factor-Binding Protein 2 (IGFBP-2), Epidermal Growth Factor (EGF), Platelet-Derived Growth Factor-BB (PDGF-BB), and Vascular Endothelial Growth Factor (VEGF) are associated with response to TSD + LT in 26 inpatients affected by a major depressive episode in the course of bipolar disorder. Regional grey matter (GM) volumes were assessed at baseline, and BOLD fMRI neural responses to a moral valence decision task were recorded before and after treatment. 61.5 % of patients responded to treatment. SCF plasma levels increased significantly more in responders, and correlated with GM volumes in frontal and parietal cortical areas. The pattern of change of SCF also associated with both GM volumes and changes of BOLD fMRI neural responses in the anterior cingulate and medial prefrontal cortex. SCF is both a hematopoietic growth factor and a neurotrophic factor, involved in neuron-neuron and neuron-(micro) glia interactions, fostering neuronal growth and an anti-inflammatory milieu. We correlated SCF levels with antidepressant response and with functional and structural MRI measures in cortical areas that are involved in the cognitive generation and control of affect. SCF may be a candidate growth factor that contributes to neurotrophic and immune effects that are involved in the process of remission/recovery from depression.
Similar content being viewed by others
References
Agis-Balboa RC, Fischer A (2014) Generating new neurons to circumvent your fears: the role of IGF signaling. Cell Mol Life Sci 71:21–42
Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM (2009) Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry 195:194–201
Arnone D, McIntosh AM, Ebmeier KP, Munafo MR, Anderson IM (2012) Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur Neuropsychopharmacol 22:1–16
Arnone D, McKie S, Elliott R, Juhasz G, Thomas EJ, Downey D, Williams S, Deakin JF, Anderson IM (2013) State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry 18:1265–1272
Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38:95–113
Barrett LF, Mesquita B, Ochsner KN, Gross JJ (2007) The experience of emotion. Annu Rev Psychol 58:373–403
Baxter LR Jr (1985) Can lithium carbonate prolong the antidepressant effect of sleep deprivation? Arch Gen Psychiatry 42:635
Benedetti F (2012) Antidepressant chronotherapeutics for bipolar depression. Dialogues Clin Neurosci 14:401–411
Benedetti F, Smeraldi E (2009) Neuroimaging and genetics of antidepressant response to sleep deprivation: implications for drug development. Curr Pharm Des 15:2637–2649
Benedetti F, Colombo C, Barbini B, Campori E, Smeraldi E (1999) Ongoing lithium treatment prevents relapse after total sleep deprivation. J Clin Psychopharmacol 19:240–245
Benedetti F, Barbini B, Fulgosi MC, Colombo C, Dallaspezia S, Pontiggia A, Smeraldi E (2005) Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: Acute response and long-term remission rates. J Clin Psychiatry 66:1535–1540
Benedetti F, Bernasconi A, Blasi V, Cadioli M, Colombo C, Falini A, Lorenzi C, Radaelli D, Scotti G, Smeraldi E (2007) Neural and genetic correlates of antidepressant response to sleep deprivation - A functional magnetic resonance imaging study of moral valence decision, in bipolar depression. Arch Gen Psychiatry 64:179–187
Benedetti F, Barbini B, Bernasconi A, Fulgosi MC, Campori E, Colombo C, Dallaspezia S, Lorenzi C, Pontiggia A, Radaelli D, Smeraldi E (2008) Lithium overcomes the influence of 5-HTTLPR gene polymorphism on antidepressant response to sleep deprivation. J Clin Psychopharmacol 28:249–251
Benedetti F, Radaelli D, Bernasconi A, Dallaspezia S, Colombo C, Smeraldi E (2009a) Changes in medial prefrontal cortex neural responses parallel successful antidepressant combination of venlafaxine and light therapy. Arch Ital Biol 147:83–93
Benedetti F, Calabrese G, Bernasconi A, Cadioli M, Colombo C, Dallaspezia S, Falini A, Radaelli D, Scotti G, Smeraldi E (2009b) Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression. Psychiatry Res 173:238–242
Benedetti F, Barbini B, Bernasconi A, Fulgosi MC, Dallaspezia S, Gavinelli C, Locatelli C, Lorenzi C, Pirovano A, Radaelli D, Smeraldi E, Colombo C (2010) Acute antidepressant response to sleep deprivation combined with light therapy is influenced by the catechol-O-methyltransferase Val(108/158)Met polymorphism. J Affect Disord 121:68–72
Benedetti F, Dallaspezia S, Lorenzi C, Pirovano A, Radaelli D, Locatelli C, Poletti S, Colombo C, Smeraldi E (2012) Gene-gene interaction of glycogen synthase kinase 3-beta and serotonin transporter on human antidepressant response to sleep deprivation. J Affect Disord 136:514–519
Benedetti F, Riccaboni R, Locatelli C, Poletti S, Dallaspezia S, Colombo C (2014) Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression. J Clin Psychiatry 75:133–140
Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, Steiner J, Connor TJ, Harkin A, Versnel MA, Drexhage HA (2012) The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol 92:959–975
Blair KS, Smith BW, Mitchell DG, Morton J, Vythilingam M, Pessoa L, Fridberg D, Zametkin A, Sturman D, Nelson EE, Drevets WC, Pine DS, Martin A, Blair RJ (2007) Modulation of emotion by cognition and cognition by emotion. NeuroImage 35:430–440
Bollettini I, Locatelli C, Poletti S, Vai B, Smeraldi E, Colombo C, Benedetti F (2014) Disruption of white matter integrity marks poor antidepressant response in bipolar disorder. J Affect Disord 174:233–240
Bredt DS, Furey ML, Chen G, Lovenberg T, Drevets WC, Manji HK (2015) Translating depression biomarkers for improved targeted therapies. Neurosci Biobehav Rev 59:1–15
Brunoni AR, Machado-Vieira R, Zarate CA Jr, Vieira EL, Vanderhasselt MA, Nitsche MA, Valiengo L, Bensenor IM, Lotufo PA, Gattaz WF, Teixeira AL (2014) BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial. Eur Neuropsychopharmacol 24:1144–1151
Brunoni AR, Machado-Vieira R, Zarate CA Jr, Vieira EL, Valiengo L, Bensenor IM, Lotufo PA, Gattaz WF, Teixeira AL (2015) Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis. Prog Neuro-Psychopharmacol Biol Psychiatry 56:91–96
Buchsbaum MS, Wu J, Siegel BV, Hackett E, Trenary M, Abel L, Reynolds C (1997) Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 41:15–22
Calabrese F, Molteni R, Maj PF, Cattaneo A, Gennarelli M, Racagni G, Riva MA (2007) Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 32:2351–2359
Canali P, Sferrazza Papa G, Casali AG, Fecchio M, Pigorini A, Schiena G, Smeraldi B, Colombo C, Benedetti F (2014) Changes of cortical excitability as biomarkers of antidepressant response in bipolar depression. Bipolar Disord 16:809–819
Carvalho AF, Kohler CA, McIntyre RS, Knochel C, Brunoni AR, Thase ME, Quevedo J, Fernandes BS, Berk M (2015) Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis. Psychoneuroendocrinology 62:18–26
Casarotto S, Canali P, Rosanova M, Pigorini A, Fecchio M, Mariotti M, Lucca A, Colombo C, Benedetti F, Massimini M (2012) Assessing the effects of electroconvulsive therapy on cortical excitability by means of transcranial magnetic stimulation and electroencephalography. Brain Topogr 26(2):326–337
Cooke JD, Grover LM, Spangler PR (2009) Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus. Neuroscience 162:1411–1419
Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K (2002) Depression: perspectives from affective neuroscience. Annu Rev Psychol 53:545–574
Dhandapani KM, Wade FM, Wakade C, Mahesh VB, Brann DW (2005) Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFkappaB. J Neurochem 95:9–19
Diniz BS, Sibille E, Ding Y, Tseng G, Aizenstein HJ, Lotrich F, Becker JT, Lopez OL, Lotze MT, Klunk WE, Reynolds CF, Butters MA (2014) Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression. Mol Psychiatry 20(5):594–601
Dreimuller N, Schlicht KF, Wagner S, Peetz D, Borysenko L, Hiemke C, Lieb K, Tadic A (2012) Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression. Neuropharmacology 62:264–269
Ebert D, Berger M (1998) Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation. Psychopharmacology 140:1–10
Erlandsson A, Larsson J, Forsberg-Nilsson K (2004) Stem cell factor is a chemoattractant and a survival factor for CNS stem cells. Exp Cell Res 301:201–210
Fornaro M, Escelsior A, Rocchi G, Conio B, Magioncalda P, Marozzi V, Presta A, Sterlini B, Contini P, Amore M, Fornaro P, Martino M (2014) BDNF plasma levels variations in major depressed patients receiving duloxetine. Neurol Sci 36(5):729–734
Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21–36
Guest PC, Bahn S (2011) Biomarkers of Neurological and Psychiatric Disease. Academic Press, London
Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, Iqbal S, Mahoney JJ 3rd, La Garza R D 2nd, Charney ,DS, Newton TF, Mathew SJ (2014) Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol 17:331–336
Hayon Y, Dashevsky O, Shai E, Varon D, Leker RR (2012) Platelet microparticles promote neural stem cell proliferation, survival and differentiation. J Mol Neurosci 47:659–665
Hetzel G, Moeller O, Evers S, Erfurth A, Ponath G, Arolt V, Rothermundt M (2005) The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology 178:161–166
Hill T, Lewicki P (2006) Statistics: methods and applications. A comprehensive reference for science, industry, and data mining. General Linear Models, StatSoft. Tulsa (OK) Chapter 18:245–276
Hirota S, Ito A, Morii E, Wanaka A, Tohyama M, Kitamura Y, Nomura S (1992) Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: an analysis using in situ hybridization histochemistry. Brain Res Mol Brain Res 15:47–54
Jin K, Mao XO, Sun Y, Xie L, Greenberg DA (2002) Stem cell factor stimulates neurogenesis in vitro and in vivo. J Clin Invest 110:311–319
Kalia M, Costa ESJ (2015) Biomarkers of psychiatric diseases: current status and future prospects. Metabolism 64:S11–S15
Kirby ED, Kuwahara AA, Messer RL, Wyss-Coray T (2015) Adult hippocampal neural stem and progenitor cells regulate the neurogenic niche by secreting VEGF. Proc Natl Acad Sci U S A 112:4128–4133
Klein A, Andersson J, Ardekani BA, Ashburner J, Avants B, Chiang MC, Christensen GE, Collins DL, Gee J, Hellier P, Song JH, Jenkinson M, Lepage C, Rueckert D, Thompson P, Vercauteren T, Woods RP, Mann JJ, Parsey RV (2009) Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 46:786–802
Kondo T, Katafuchi T, Hori T (2002) Stem cell factor modulates paired-pulse facilitation and long-term potentiation in the hippocampal mossy fiber-CA3 pathway in mice. Brain Res 946:179–190
Kovacs KJ, Foldes A, Vizi ES (1996) C-kit ligand (Stem Cell Factor) affects neuronal activity, stimulates pituitary-adrenal axis and prolactin secretion in rats. J Neuroimmunol 65:133–141
Levesque J, Eugene F, Joanette Y, Paquette V, Mensour B, Beaudoin G, Leroux JM, Bourgouin P, Beauregard M (2003) Neural circuitry underlying voluntary suppression of sadness. Biol Psychiatry 53:502–510
Licznerski P, Duman RS (2013) Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression. Neuroscience 251:33–50
Millan MJ (2006) Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 110:135–370
Miller BR, Hen R (2015) The current state of the neurogenic theory of depression and anxiety. Curr Opin Neurobiol 30:51–58
Motro B, van der Kooy D, Rossant J, Reith A, Bernstein A (1991) Contiguous patterns of c-kit and steel expression: analysis of mutations at the W and Sl loci. Development 113:1207–1221
Nakano T, Lai CY, Goto S, Hsu LW, Kawamoto S, Ono K, Chen KD, Lin CC, Chiu KW, Wang CC, Cheng YF, Chen CL (2012) Immunological and regenerative aspects of hepatic mast cells in liver allograft rejection and tolerance. PLoS One 7:e37202
Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E, Duman RS (2003) Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 23:10841–10851
Ochsner KN, Gross JJ (2005) The cognitive control of emotion. Trends Cogn Sci 9:242–249
Oriss TB, Krishnamoorthy N, Ray P, Ray A (2014) Dendritic cell c-kit signaling and adaptive immunity: implications for the upper airways. Curr Opin Allergy Clin Immunol 14:7–12
Pan PY, Wang GX, Yin B, Ozao J, Ku T, Divino CM, Chen SH (2008) Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood 111:219–228
Phillips JL, Batten LA, Aldosary F, Tremblay P, Blier P (2012) Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression. J Clin Psychiatry 73:625–631
Ray P, Krishnamoorthy N, Ray A (2008) Emerging functions of c-kit and its ligand stem cell factor in dendritic cells: regulators of T cell differentiation. Cell Cycle 7:2826–2832
Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF (2006) Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 31:1841–1853
Schmohl M, Schneiderhan-Marra N, Baur N, Hefner K, Blum M, Stein GM, Joos TO, Schmolz M (2012) Characterization of immunologically active drugs in a novel organotypic co-culture model of the human gut and whole blood. Int Immunopharmacol 14:722–728
Soumiya H, Fukumitsu H, Furukawa S (2009) Stem cell factor induces heterotopic accumulation of cells (heterotopia) in the mouse cerebral cortex. Biomed Res 30:121–128
Stelzhammer V, Guest PC, Rothermundt M, Sondermann C, Michael N, Schwarz E, Rahmoune H, Bahn S (2013) Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients. Eur Neuropsychopharmacol 23:1199–1207
Su Y, Cui L, Piao C, Li B, Zhao LR (2013) The effects of hematopoietic growth factors on neurite outgrowth. PLoS One 8:e75562
Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M (2006) Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 58:115–134
Vai B, Poletti S, Radaelli D, Dallaspezia S, Bulgarelli C, Locatelli C, Bollettini I, Falini A, Colombo C, Smeraldi E, Benedetti F (2015) Successful antidepressant chronotherapeutics enhance fronto-limbic neural responses and connectivity in bipolar depression. Psychiatry Res 233:243–253
Vasefi MS, Kruk JS, Heikkila JJ, Beazely MA (2013) 5-Hydroxytryptamine type 7 receptor neuroprotection against NMDA-induced excitotoxicity is PDGFbeta receptor dependent. J Neurochem 125:26–36
Vyazovskiy VV, Cirelli C, Pfister-Genskow M, Faraguna U, Tononi G (2008) Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nat Neurosci 11:200–208
Wirz-Justice A, Benedetti F, Berger M, Lam RW, Martiny K, Terman M, Wu JC (2005) Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med 35:939–944
Wirz-Justice A, Benedetti F, Terman M (2013) Chronotherapeutics for Affective Disorders. A Clinician’s Manual for Light and Wake Therapy, II edn. Karger, Basel
Wong RW, Guillaud L (2004) The role of epidermal growth factor and its receptors in mammalian CNS. Cytokine Growth Factor Rev 15:147–156
Wong ML, Licinio J (1994) Localization of stem cell factor mRNA in adult rat hippocampus. Neuroimmunomodulation 1:181–187
Wu JC, Buchsbaum M, Bunney WE Jr (2001) Clinical neurochemical implications of sleep deprivation’s effects on the anterior cingulate of depressed responders. Neuropsychopharmacology 25:S74–S78
Yang J, Yang C, Liu C, Zhang T, Yang Z (2015) Paradoxical effects of VEGF on synaptic activity partially involved in notch1 signaling in the mouse hippocampus. Hippocampus. doi:10.1002/hipo.22544
Zhang SC, Fedoroff S (1997) Cellular localization of stem cell factor and c-kit receptor in the mouse nervous system. J Neurosci Res 47:1–15
Zhang SC, Fedoroff S (1998) Modulation of microglia by stem cell factor. J Neurosci Res 53:29–37
Zhao LR, Navalitloha Y, Singhal S, Mehta J, Piao CS, Guo WP, Kessler JA, Groothuis DR (2007) Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Exp Neurol 204:569–573
Zhong Y, Takemoto M, Fukuda T, Hattori Y, Murakami F, Nakajima D, Nakayama M, Yamamoto N (2004) Identification of the genes that are expressed in the upper layers of the neocortex. Cereb Cortex 14:1144–1152
Acknowledgments
We appreciate excellent technical assistance by Christiane Schettler and Kordula Vorspohl.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding and disclosure
This study was supported by the European Union EU-FP7-HEALTH-F2–2008-222,963 “MOODINFLAME” and EU-FP7-PEOPLE-2009-IAPP “PSYCH-AID” projects.
None of the authors have financial disclosures or conflicts of interest pertinent to the contents of the manuscript.
Electronic Supplementary Material
ESM 1
(DOCX 815 kb)
Rights and permissions
About this article
Cite this article
Benedetti, F., Poletti, S., Hoogenboezem, T.A. et al. Stem Cell Factor (SCF) is a putative biomarker of antidepressant response. J Neuroimmune Pharmacol 11, 248–258 (2016). https://doi.org/10.1007/s11481-016-9672-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-016-9672-y